Recent Norwegian research suggests that naltrexone implants could significantly reduce heroin dependency, which could have an enormous impact on available treatments for heroin addicts. Unlike naltrexone, current treatments for heroin addiction typically involve the use of other addictive morphine-like substances, such as methadone and Subutex. “Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. It is marketed in generic form as its hydrochloride salt, naltrexone hydrochloride, and marketed under the trade names Revia and Depade.”Researchers studied roughly 56 willing heroin-dependent patients. Twenty-three of the participants had a total of 20 pellets surgically implanted just beneath the skin, which contained naltrexone and a saline solution that allowed for a slow release of the medication to generate a six-